Effector Cells of Both Nonhemopoietic and Hemopoietic Origin Are Required for Interferon (IFN)-γ– and Tumor Necrosis Factor (TNF)-α–dependent Host Resistance to the Intracellular Pathogen, <i>Toxoplasma gondii </i>
George Yap(Rutgers, The State University of New Jersey), Alan Sher(National Institutes of Health)
Cited by 244
Related Papers
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
|Nature|2014|776
Successful T cell priming in B cell-deficient mice.
|The Journal of Experimental Medicine|1995|275
Heme oxygenase-1 inhibition promotes IFNγ- and NOS2-mediated control of Mycobacterium tuberculosis infection
|Mucosal Immunology|2020|33